Track URGN and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
URGN - UroGen Pharma Ltd (URGN) has a earnings per share of -$0.47, up 48.9% over the past year.
Latest EPS (Actual)
-$0.47
Beat Rate
12.5%
Most Recent
Meet
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.46 | -$0.47 | Meet | -1.47% |
| Mar 2026 | -$0.48 | -$0.53 | Miss | -9.94% |
| Nov 2025 | -$0.68 | -$0.69 | Meet | -1.47% |
| Aug 2025 | -$0.82 | -$1.05 | Miss | -28.05% |
| May 2025 | -$0.80 | -$0.92 | Miss | -15.72% |
| Mar 2025 | -$0.72 | -$0.80 | Miss | -11.11% |
| Nov 2024 | -$0.82 | -$0.55 | Beat | +32.93% |
| Aug 2024 | -$0.83 | -$0.91 | Miss | -9.64% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.